Due to a measles case in the community, please call before coming to Seattle Children’s if you or your child has potential measles symptoms.

Current Research Studies

AGCT1532_Accelerated BEP

Condition: Germ Cell Tumors
Phase: III
Clinicaltrials.gov ID: NCT02582697

What is the goal of the study?

The overall goal of this study is to determine whether accelerated BEP will be effective and well-tolerated for patients with advanced germ cell tumors. We don't yet know if accelerated treatment is helpful in advanced germ cell tumors and we are hoping this study will answer that question.

Who can participate in the study?

This study may be a good fit for indidivuals with an intermediate and poorrisk metastatic germ cell tumor. For details about study eligibility, read more about this study on clinicaltrials.gov.

Study Team:

PI (Study Doctor): Tyler Ketterl
Study Team Member: HemOnc CRAs, HemOncCRAs@seattlechildrens.org

Seattle Children’s complies with applicable federal and other civil rights laws and does not discriminate, exclude people or treat them differently based on race, color, religion (creed), sex, gender identity or expression, sexual orientation, national origin (ancestry), age, disability, or any other status protected by applicable federal, state or local law. Financial assistance for medically necessary services is based on family income and hospital resources and is provided to children under age 21 whose primary residence is in Washington, Alaska, Montana or Idaho.